Amphetamine/Methamphetamine Confirm, Urine

Orderable EAP code:

LAB100063

Billable EAP Codes:

80002005 x 1
80005697 x 1

CPT Codes:

80325 x 1
80359 x 1

Lab Section:

Biochemical Genetics

Turnaround Time:

7 to 10 Days

Test Schedule:

Once per week

Units:

ng/mL

Interpretation:

A result of 500 ng/mL is a strong indicator that the patient has used these drugs within the past three days.

Specimen Requirements:

1 mL (500 microliters minimum) urine in sample cup. Stable 7 Days ambient, 14 days refrigerated, 30 days frozen.

Pediatric Specimen Requirements:

1 mL (500 microliters minimum) urine in sample cup. Stable 7 Days ambient, 14 days refrigerated, 30 days frozen.

Reference Range:

Negative. Confirmation Cut-off: Amphetamine, Methamphetamine, MDA, MDMA, MDEA, and Ephedrine are reported as positive if greater than 200 ng/ml.

Comments:

The presence of amphetamines in urine at concentrations greater than 500 ng/mL is a strong indicator that the patient has used these drugs within the past 3 days.
Methylenedioxyamphetamine (MDA) is a metabolite of MDMA and MDEA.
This confirmatory method does not detect Methylphenidate.
This test will produce positive results for urine specimens collected from patients who are administered Adderall and Benzedrine; Desoxyn and Vicks Vapoinhaler; Selegiline (metabolized to methamphetamine and amphetamine); and clobenzorex, famprofazone, fenethylline, fenproporex, and mefenorex, which are amphetamine pro-drugs.
Results confirmed by mass spectroscopy. This is a lab-developed test not evaluated by the FDA. These results are for clinical use only.